Search

Search Constraints

You searched for: Author/Creator Belli, C.

Search Results

11. PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS. (23rd June 2022)

12. Relevance of Cytogenetics in Myelodysplastic Syndrome (MDS) in the Assessment of Hematopoietic Stem Cell Transplantation (HSCT) Survival. (April 2017)

14. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): APPLICATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M) MODEL IN SOUTH-AMERICAN MDS PATIENTS: A STUDY FROM ARGENTINA AND URUGUAY. (May 2023)

15. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): MOLECULAR PROFILE OF MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS. REAL WORLD DATA FROM ARGENTINA AND URUGUAY. (May 2023)

16. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): REAL-WORLD LABORATORY PRACTICE PATTERNS ON NEXT-GENERATION-SEQUENCING (NGS) TECHNOLOGY IN LATIN AMERICA. (May 2023)

17. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ALTERNATIVE DOSING SCHEDULES OF AZACITIDINE: A REAL-WORLD COMPARATIVE STUDY ACROSS SOUTH AMERICAN CENTERS. (May 2023)

18. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?. (May 2023)